<DOC>
	<DOCNO>NCT00630513</DOCNO>
	<brief_summary>The aim study compare activity ( efficacy safety ) Ertapenem administer accord short treatment three day versus short treatment three day AS patient community acquire IAI mild moderate severity .</brief_summary>
	<brief_title>T.E.A . Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam</brief_title>
	<detailed_description>The study project prospective , randomize control investigation . The study perform Department Transplant , General Emergency Surgery St Orsola-Malpighi University Hospital ( Bologna , Italy ) , large teach institution , participation surgeon accept involve . The study design conduct compliance principle Good Clinical Practice regulation . The tolerability efficacy 3 day treatment Ampicillin- Sulbactam ( AS 3g x 3/ day i.v . ) compare 3 day regimen Ertapenem ( 1 g/day i.v. ) . patient localize peritonitis blind evaluation efficacy end point . Evaluation cure failure blind use designate third party individual unaware treatment assign patient .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Adult patient ( &gt; 18 year ) require surgical intervention within 24 hour diagnosis , localize IAI infection ( i.e extend beyond organ wall confine near hollow viscus , mild moderate severity ) : Acute appendicitis : Ruptured perforate abscess Acute diverticulitis perforation and/or abscess Acute cholecystitis ( include gangrenous ) either rupture perforation Acute gastric duodenal ( &gt; 24 hour ) perforation Traumatic ( &gt; 12 hour ) perforation intestine Secondary peritonitis due perforate viscus Intraabdominal abscess ( include liver spleen ) Traumatic bowel perforation require surgery within 12 hour Perforation gastroduodenal ulcer require surgery within 24 hour intraabdominal process primary etiology unlikely infectious . Patients lactate pregnant Patients history allergy , hypersensitivity , severe reaction study antibiotic Patients rapidly progressive terminal illness ; Patients history presence severe hepatic renal disease ( e.g . creatinine clearance &lt; 0.5 ml/min/1.73 m2 ) ; Patients concomitant infection would interfere evaluation response study antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>localize community acquire intra-abdominal infection ( IAI )</keyword>
	<keyword>antibiotic</keyword>
	<keyword>localize peritonitis</keyword>
	<keyword>ertapenem</keyword>
</DOC>